Intuitive Surgical Inc(ISRG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 6:34 PM ET (Korea 10/24 07:34)
Full metrics table
| Index | NDX, S&P 500 | P/E | 54.72 | EPS (ttm) | 8.27 | Insider Own | 0.7% | Shs Outstand | 346.6M | Perf Week | 6% |
| Market Cap | 156.78B | Forward P/E | 36.49 | EPS next Y | 10.52% | Insider Trans | -0.8% | Shs Float | 344.2M | Perf Month | 13.21% |
| Enterprise Value | 152.84B | PEG | 2.28 | EPS next Q | 2.95 | Inst Own | 91.37% | Short Float | 2.15% | Perf Quarter | 26.75% |
| Income | 2.96B | P/S | 13.54 | EPS this Y | 25.59% | Inst Trans | 0.12% | Short Ratio | 2.9 | Perf Half Y | -6.21% |
| Sales | 11.58B | P/B | 9.81 | EPS next 5Y | 16.02% | ROA | 15.28% | Short Interest | 7.41M | Perf YTD | -20.14% |
| Book/sh | 46.12 | P/C | 38.5 | EPS past 3/5Y | 29.18% 21.79% | ROE | 17.97% | 52W High | -25.1% ($603.88) | Perf Year | -17.96% |
| Cash/sh | 11.75 | P/FCF | 43.58 | Sales past 3/5Y | 17.39% 18.22% | ROIC | 18.5% | 52W Low | 37.65% ($328.57) | Perf 3Y | 65.92% |
| Dividend Est. | - | EV/EBITDA | 33.93 | EPS Y/Y TTM | 8.75% | Gross Margin | 67.17% | Volatility(W/M) | 3.95% 3.04% | Perf 5Y | 32.43% |
| Dividend TTM | - | EV/Sales | 13.2 | Sales Y/Y TTM | 20.45% | Oper. Margin | 32.25% | ATR (14) | 13.22 | Perf 10Y | 500.37% |
| Dividend Ex-Date | - | Quick Ratio | 2.49 | EPS Q/Q | -23.63% | Profit Margin | 25.54% | RSI (14) | 70.84 | Recom | 1.78 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.33 | Sales Q/Q | 21.7% | SMA20 | 7.54% ($420.58) | Beta | 1.46 | Target Price | $484.34 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/10/20 | SMA50 | 14.2% ($396.05) | Rel Volume | 1.18 | Prev Close | $443.85 |
| Employees | 17021 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 13.37% 4.88% | SMA200 | 3.69% ($436.19) | Avg Volume(3M) | 2.56M | Price | $452.29 |
| IPO | 2000/6/13 | Option/Short | Yes/Yes | Trades | 67883 | Volume | 3,005,113 | Change | 1.9% |
Intuitive Surgical is a global leader in medical robotics, developing and supplying the da Vinci surgical robot system. Headquartered in Sunnyvale, California, USA, the company was founded in 1995 and has established itself as the global standard in minimally invasive robotic surgery. Its business model is characterized not only by system sales but also by recurring revenue from disposable instruments and services.
Over the past 1 year, roughly in the middle
25% below its 1-year high.
Traded about as much as usual. That is 118% of its average volume.
ISRG makes money exceptionally well
Of every $100 in sales, $32.25 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +25.6% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $5,472. Peers typically go for $3,199. Compared with its own 5-year average, it is 23% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +32.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 91.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IHI iShares U.S. Medical Devices ETF 0.15% 
LGHT Langar Global HealthTech ETF 0.10% 
BOTZ Global X Funds Global X Robotics & Artificial Intelligence ETF 0.06% 
EKG First Trust Nasdaq Lux Digital Health Solutions ETF 0.06% 
GDOC Goldman Sachs Future Health Care Equity ETF 0.04% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
ISUL GraniteShares 2x Long ISRG Daily ETF 11M It is the largest in the industry
Based on market cap of $157B.
ISRG#1 Intuitive Surgical Inc $157B PER 54.7 
BDX#2 Becton Dickinson & Co $54B PER 60.0 
MDLN#3 Medline Inc $45B PER 40.0 
RMD#4 Resmed Inc $36B PER 24.2 
ALC#5 Alcon Inc $34B PER 53.8 
FAQ
What kind of company is ISRG?
ISRG belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ISRG?
The market cap of ISRG is approximately $156.8B, ranking 99 within its sector.
What is the P/E ratio of ISRG?
ISRG has a P/E ratio of approximately 54.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ISRG?
ISRG has recorded a 52-week high of $603.88 and a low of $328.57.
